Antimutagenic effects of centchroman - A contraceptive and a candidate drug for breast cancer in multiple mutational assays

Mutagenesis

Volumn 14, Issue 6, 1999, Pages 613-619

  Giri, Ashok K ^a   Mukhopadhyay, Amitabha ^a   Sun, J ^b   Hsie, Abraham W ^b   Ray, Suprabhat ^c  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b University of Texas Medical Branch School of Medicine   (United States)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORENYLAMINE; 4 NITRO 1,2 PHENYLENEDIAMINE; ANTIESTROGEN; ANTIMUTAGENIC AGENT; CENTCHROMAN; CONTRACEPTIVE AGENT; CUMENE HYDROPEROXIDE; CYCLOPHOSPHAMIDE; DANTRON; DIMETHYLBENZ[A]ANTHRACENE; HISTIDINE; MESYLIC ACID ETHYL ESTER; MITOMYCIN C; SODIUM AZIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BACTERIUM; BREAST CANCER; CANCER REGRESSION; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; MUTAGENESIS; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA; SISTER CHROMATID EXCHANGE;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; SALMONELLA;

EID: 0032746605     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.6.613     Document Type: Article

References (36)

1. Anand, N. and Ray, S. (1977) A post-coital contraceptive agent. Indian J. Exp. Biol., 15, 1142-1143.
2. An, J. and Hsie, A.W. (1992) Effects of an inhibitor and a mimic of Superoxide dismutase on bleomycin mutagenesis in Chinese hamster overy cells. Mutat. Res., 270, 167-175.
3. Central Drug Research Institute (1991) Dossier of Centchroman, Vol. 18. Central Drug Research Institute, Lucknow, India.
4. Central Drug Research Institute (1995) Annual Report of the Central Drug Research Institute 1994-95. Area Antifertility. Centchroman Phase III Trials in Advanced Cancer of Breast. Maheshwari & Sons, Lucknow, India, p. 1.
5. Dunnett, C.W. (1955) A multiple comparison procedure for comparing several treatments with the control. J. Am. Statist. Assoc., 50, 1096-1121.
6. Eldridge, A.C. (1982) Determination of isoflavones in soya-bean flours, protein concentrates and isolates. J. Agric. Food Chem., 30, 353-355.
7. Ferlini, C., Scambia, G., Distefano, M., Filippini, P., Isola, G., Riva, A., Bombardelli, E., Fattorossi, A., Benedetti Panici, P. and Mancuso, S. (1997) Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. Br. J. Cancer, 75, 884-891.
8. Giri, A.K. (1996) Genetic toxicology of four commonly used benzodiazepines: a review. Mutat. Res., 340, 93-108.
9. Giri, A.K. (1997) Genetic toxiclogy of epichlorohydrin: a review. Mutat. Res., 386, 25-38.
10. Giri, A.K. and Khan, K.A. (1995) Absence of sister chromatid exchange and chromosome aberrations in mice after in vivo exposure of Centchroman - a new non-steroidal oral contraceptive. Cytologia, 60, 167-172.
11. Giri, A.K. and Lu, L.J.W. (1995) Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett., 95, 125-133.
12. Giri, A.K., Sai Sivam, S., Khan, K.A. and Sethi, N. (1992) Sister chromatid exchange and chromosome aberrations in mice after in vivo exposure of Green S - a food colorant. Environ. Mol. Mutagen., 19, 223-226.
13. Hsie, A.W., Briner, P.A., Mitchell, T.J. and Gosslee, D.G. (1975) The dose response relationships for ethyl methansulphonate-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells. Somat. Cell Genet., 1, 247-261.
14. Hsie, A.W., Cassiano, D.A., Couch, D.B., Krahn, D.G., O'Neill, J.P. and Whitfield, B.L. (1981) The use of chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals: a report of the GENE-TOX programme. Mutat. Res., 86, 193-214.
15. Hsie, A.W., Resio, L., Katz, K.S., Lee, C.Q., Wagner, M. and Schenley, R.L. (1986) Evidence for reactive oxygen species inducing mutations in mammalian cells. Proc. Natl Acad. Sci. USA, 83, 9616-9620.
16. Ivett, J.L. and Tice, R.R. (1982) Average generation time: a new method for analyzing cellular proliferation kinetics based on bromodeoxyuridine-dependent chromosome differential staining patterns. Environ. Mutagen., 4, 358-364.
17. Kamboj, V.P. (1979) In Talwar, G.P. (ed.), Recent Advances in Reproduction and Regulation of Fertility. Elsevier, Amsterdam, The Netherlands, p. 353.
18. Kamboj, V.P., Setty, B.S., Chandra, H., Roy, S.K. and Kar, A.B. (1977) Biological profile of centchroman - a new postcoital contraceptive. Indian J. Exp. Biol., 15, 1140-1150.
19. Maron, D.M. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
20. Martin, P.M., Horwitz, K.B., Ryan, D.S. and McGuire, W.L. (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer. Endocrinology, 103, 1860-1867.
21. McFee, A.F., Lowe, K. and San Sebastian, J.R. (1983) Improved sister chromatid differentiation using paraffin coated bromodeoxyuridine tablets in mice. Mutat. Res., 119, 83-88.
22. Michaelis, K., Helvering, L., Kinding, D., Garriott, M. and Richardson, S. (1992) Localization of the xanthine guanine phosphoribosyltransferase gene (gpt) of E.coli in AS52 metaphase cells by fluorescence in situ hybridization. Environ. Mol. Mutagen., 19 (suppl. 20), 42.
23. Mishra, N.C., Nigam, P.K., Gupta, R., Agarwal, A.K. and Kamboj, V.P. (1989) Centchroman - a nonsteroidal anticancer agent for advanced breast cancer: phase II study. Int. J. Cancer, 43, 781-783.
24. Mukherjee, S.S., Sethi, N., Srivastava, G.N., Roy, A.K., Nityanand, S. and Mukherjee, S.K. (1977) Chronic toxicity studies of centchroman in rats and rhesus monkeys. Indian J. Exp. Biol., 15, 1151-1153.
25. Perry, P. and Wolf, S. (1974) New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156-158.
26. Philipose, B., Singh, R., Khan, K.A. and Giri, A.K. (1997) Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat. Res., 393, 123-131.
27. Preston, R.J., Dean, B.J., Galloway, S., Holden, H., McFee, A.F. and Shelby, M. (1987) Mammalian in vivo cytogenetic assays: analysis of chromosome aberrations in bone marrow cells. Mutat. Res., 189, 157-165.
28. Price, K.R. and Fenwick, G.R. (1985) Naturally occurring oestrogens in food - a review. Food Addit. Contam., 2, 73-106.
29. Ray, S., Tandon, A., Dwivedy, I., Wilson, S.R., O'Neil, J.P. and Katzennellengogen, J.A. (1994) An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman. J. Med. Chem., 37, 696-700.
30. Salman, M., Ray, S., Anand, N., Agarwal, A.K., Singh, M.M., Setty, B.S. and Kamboj, V.P. (1986) Studies in antifertility agents 50. Stereo-selective binding of d- and 1-centchromans to estrogen receptor and their anti-fertility activity. J. Med. Chem., 29, 1801-1803.
31. Sharief, Y., Brown, A.M., Backer, L.C., Campbell, J.L., Westbrook-Collins, B., Stead, A.G. and Allen, J.W. (1986) Sister chromatid exchange and chromosome aberration analyses in mice after in vivo exposure to acrylonitrile, styrene, or butadiene monoxide. Environ. Mutagen., 8, 439-448.
32. Stob, M. (1983) Naturally occurring food toxicants: estrogens. In Rechcigal, M., Jr (ed.), CRC Handbook of Naturally Occurring Food Toxicants. CRC Press, Boca Raton, FL, pp. 81-100.
33. Tindall, K.R., Stankowski, L.F. Jr, Machanoff, R. and Hsie, A.W. (1984) Detection of deletion of mutations in pSV2 gpt-transformed cells. Mol. Cell. Biol., 4, 1411-1415.
34. Tindall, K.R., Stankowski, L.F. Jr, Machanoff, R. and Hsie, A.W. (1986) Analyses of mutation in pSV2 gpt-transformed CHO cells. Mutat. Res., 160, 121-131.
35. Verdeal, K., Brown, R.R., Richardson, T. and Ryan, D.S. (1980) Affinity of phytooestrogens for the oestradiol-binding proteins and effect of coumestrol on the growth of 7,12-dimethylbenz[a]anthracene induced rat mammary tumors. J. Natl Cancer Inst., 64, 285-290.
36. World Health Organization (1985) Environmental Health Criteria, Vol. 46, Guidelines for the Study of Genetic Effects in Human Populations. WHO, Geneva, Switzerland, pp. 29-44.